Enveric Biosciences (NASDAQ: ENVB) agreed to license one of its experimental psychedelic drug candidates to MycoMedica Life Sciences in a deal worth as much as $62 million, as the biotech company keeps its eye on its non-hallucinogenic treatments. The agreement grants MycoMedica exclusive global rights to EB-002, a synthetic prodrug …
The Daily Hit is a recap of the top financial news stories for Thursday, November 7, 2024. On the Site Illinois government blamed for failing social equity cannabis businesses in new lawsuit The lawsuit claims that Gov. Pritzker’s administration implemented “discretionary policies” that led to their troubles. Read more here. …
Paco explained that it would cost him nearly twelve hundred dollars a week to care for his condition if buying from a New Jersey cannabis dispensary.
… Rhode Island. “This is the first study that VA is funding investigating … Support Marijuana Moment. Marijuana Moment · About Marijuana Moment …